ReviewFrontiers in immunology2026

Glycosylation converts CD24 from a developmental marker into a glyco-immune checkpoint in B-cell acute lymphoblastic leukemia.

Shuheng Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.